NeuroPace Income After Taxes 2020-2024 | NPCE
NeuroPace income after taxes from 2020 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
| NeuroPace Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2024 | $-27 |
| 2023 | $-33 |
| 2022 | $-47 |
| 2021 | $-36 |
| 2020 | $-24 |
| 2019 | $-30 |
| NeuroPace Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-5 |
| 2024-09-30 | $-5 |
| 2024-06-30 | $-8 |
| 2024-03-31 | $-9 |
| 2023-12-31 | $-6 |
| 2023-09-30 | $-7 |
| 2023-06-30 | $-9 |
| 2023-03-31 | $-10 |
| 2022-12-31 | $-11 |
| 2022-09-30 | $-12 |
| 2022-06-30 | $-13 |
| 2022-03-31 | $-11 |
| 2021-12-31 | $-11 |
| 2021-09-30 | $-8 |
| 2021-06-30 | $-8 |
| 2021-03-31 | $-9 |
| 2020-12-31 | $-5 |
| 2020-09-30 | $-4 |
| 2020-06-30 | $-9 |
| 2020-03-31 | $-7 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.386B | $0.080B |
| NeuroPace Inc. is a commercial-stage medical device company. It is focused on developing products to treat and transform the lives of patients suffering from epilepsy. NeuroPace Inc. is based in MOUNTAIN VIEW, Calif. | |||